These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 7518160

  • 1. Whole blood and plasma levels of FK 506 after liver transplantation: correlation with toxicity.
    Bäckman L, Nicar M, Levy M, Distant D, Eisenstein C, Renard T, Goldstein R, Husberg B, Gonwa T, Klintmalm G.
    Transplant Proc; 1994 Jun; 26(3):1804. PubMed ID: 7518160
    [No Abstract] [Full Text] [Related]

  • 2. Association of elevated FK 506 plasma levels with nephrotoxicity in liver-grafted patients.
    Winkler M, Jost U, Ringe B, Gubernatis G, Wonigeit K, Pichlmayr R.
    Transplant Proc; 1991 Dec; 23(6):3153-5. PubMed ID: 1721389
    [No Abstract] [Full Text] [Related]

  • 3. Plasma level-guided low-dose FK 506 therapy in patients with early liver dysfunction after liver transplantation.
    Winkler M, Ringe B, Jost U, Gubernatis G, Pichlmayr R.
    Transplant Proc; 1993 Aug; 25(4):2688-90. PubMed ID: 7689277
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Chronic nephrotoxicity of FK 506 after liver transplantation.
    Bäckman L, Nicar M, Levy M, Distant D, Eisenstein C, Renard T, Goldstein R, Husberg B, Gonwa T, Klintmalm G.
    Transplant Proc; 1994 Jun; 26(3):1803. PubMed ID: 7518159
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. FK 506 in liver transplantation: correlation of whole blood levels with efficacy and toxicity. The US Multicenter FK 506 Dose Optimization.
    Schwartz M, Holst B, Facklam D, Buell D.
    Transplant Proc; 1995 Feb; 27(1):1107. PubMed ID: 7533355
    [No Abstract] [Full Text] [Related]

  • 11. Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
    Klintmalm GB, Goldstein R, Gonwa T, Wiesner RH, Krom RA, Shaw BW, Stratta R, Ascher NL, Roberts JW, Lake J.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):679-88. PubMed ID: 7679840
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The use of plasma levels for FK 506 dosing in liver-grafted patients.
    Winkler M, Ringe B, Rodeck B, Melter M, Stoll K, Baumann J, Wonigeit K, Pichlmayr R.
    Transpl Int; 1994 Aug; 7(5):329-33. PubMed ID: 7527638
    [Abstract] [Full Text] [Related]

  • 16. Comparison of plasma vs whole blood as matrix for FK 506 drug level monitoring.
    Winkler M, Wonigeit K, Undre N, Ringe B, Oldhafer K, Christians U, Pichlmayr R.
    Transplant Proc; 1995 Feb; 27(1):822-5. PubMed ID: 7533433
    [No Abstract] [Full Text] [Related]

  • 17. A case of hyperkalemic distal renal tubular acidosis secondary to tacrolimus in living donor liver transplantation.
    Oishi M, Yagi T, Urushihara N, Takakura N, Inagaki M, Sadamori H, Mastukawa H, Inoue T, Oda S, Tanaka N.
    Transplant Proc; 2000 Nov; 32(7):2225-6. PubMed ID: 11120143
    [No Abstract] [Full Text] [Related]

  • 18. Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
    Klintmalm GB, Goldstein R, Gonwa T, Wiesner RH, Krom RA, Shaw BW, Stratta R, Ascher NL, Roberts JW, Lake J.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):641-3. PubMed ID: 7679828
    [No Abstract] [Full Text] [Related]

  • 19. Therapeutic monitoring of tacrolimus concentrations in blood of renal and liver transplant recipients: comparison of microparticle enzyme immunoassay and enzyme multiplied immunoassay methods.
    Bartlomiejczyk I, Zochowska D, Sanko-Resmer J, Matuszewicz D, Paczek L.
    Transplant Proc; 2006 Feb; 38(1):94-6. PubMed ID: 16504673
    [Abstract] [Full Text] [Related]

  • 20. Conversion to rescue therapy with FK 506: data from eight liver transplant patients.
    Reggiani P, Orsenigo R, Gatti S, Albani AP, Ferla G, Doglia M, Fassati LR, Galmarini D.
    Transplant Proc; 1994 Dec; 26(6):3597-8. PubMed ID: 7527982
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.